| Q44046542 | A scientific evaluation of operative choledochoscopy in acute cholangitis |
| Q34033188 | Acute (ascending) cholangitis. |
| Q40108238 | Acute Cholangitis After Bilioenteric Anastomosis for Bile Duct Injuries. |
| Q50349774 | Acute cholangitis - an update |
| Q24550551 | Acute cholangitis. Multivariate analysis of risk factors |
| Q40315336 | Acute suppurative cholangitis |
| Q42082651 | Acute suppurative obstructive cholangitis due to stones: treatment by urgent endoscopic sphincterotomy |
| Q37443672 | Antimicrobial therapy for acute cholangitis: Tokyo Guidelines |
| Q37443615 | Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines. |
| Q37443641 | Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis |
| Q46480376 | Bacterial Cholangitis |
| Q74610800 | Bacteribilia and cholangitis after percutaneous transhepatic biliary drainage for malignant biliary obstruction |
| Q37190599 | Biliary Tract Disease in the Aged |
| Q38638430 | Biliary concrements: the endoscopic approach |
| Q74662140 | Biliary decompression by nasobiliary catheter or biliary stent in acute suppurative cholangitis: a prospective randomized trial |
| Q37640566 | Biliary drainage method and temporal trends in patients admitted with cholangitis: a national audit |
| Q41725830 | Biliary infection |
| Q40845913 | Biliary tract emergencies. Acute cholecystitis, acute cholangitis, and acute pancreatitis. |
| Q39441707 | Biliary tract infections: a guide to drug treatment |
| Q50163676 | Can acute cholecystitis produce obstructive jaundice in the absence of choledocholithiasis? |
| Q37138395 | Canadian consensus on medically acceptable wait times for digestive health care |
| Q70717822 | Cholangitis due to malignant obstruction of biliary outflow |
| Q37311699 | Common Bile Duct Dilatation With Stones Indicates Requirement for Early Drainage in Patients With or Without Cholangitis |
| Q40164911 | Complications of Cholecystectomy |
| Q35229325 | Complications of hepatolithiasis |
| Q40834835 | Current dilemmas in management of common duct stones |
| Q42685241 | Diagnosis and management of acute cholangitis |
| Q35616679 | Diagnosis and management of cholecystitis and cholangitis |
| Q36718098 | Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines |
| Q36326273 | Diagnostic performance of multidetector CT for acute cholangitis: evaluation of a CT scoring method |
| Q34651326 | Disparities in outcomes following admission for cholangitis |
| Q24197934 | Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative management strategy in acute gallstone pancreatitis |
| Q24540384 | Emergency surgery for severe acute cholangitis. The high-risk patients |
| Q90092412 | Emergent Treatment of Acute Cholangitis and Acute Cholecystitis |
| Q36496470 | Empirical antibiotic treatment with piperacillin-tazobactam in patients with microbiologically-documented biliary tract infections. |
| Q40409146 | Endoscopic biliary drainage by 7 Fr or 10 Fr stent placement in patients with acute cholangitis |
| Q33909728 | Endoscopic management of acute cholangitis in elderly patients |
| Q40180162 | Endoscopic management of bile duct stones; (apples and oranges) |
| Q36767127 | Endoscopic management of biliary tract obstruction in the 1990s |
| Q57106909 | Etiologies, risk factors, and outcomes of bacterial cholangitis after living donor liver transplantation |
| Q57651544 | Factors in management of acute cholangitis |
| Q37443647 | Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo Guidelines |
| Q35312303 | Hepatobiliary kinetics and excretion of ciprofloxacin |
| Q34636789 | MR characteristics of acute cholangitis. |
| Q74499249 | MR imaging findings of infectious cholangitis |
| Q86257670 | Management for CBD stone-related mild to moderate acute cholangitis: urgent versus elective ERCP |
| Q93628878 | Management of injuries to the porta hepatis |
| Q37443635 | Need for criteria for the diagnosis and severity assessment of acute cholangitis and cholecystitis: Tokyo Guidelines |
| Q36195461 | New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines |
| Q40315343 | Pathogenesis and management of choledocholithiasis. |
| Q69995592 | Percutaneous biliary drainage in acute suppurative cholangitis |
| Q39758025 | Percutaneous drainage |
| Q57238177 | Polymicrobial bacteremia in critically ill patients |
| Q45911638 | Preventive saline irrigation of the bile duct after the endoscopic removal of common bile duct stones. |
| Q38062337 | Risk factors of organ failure in patients with bacteremic cholangitis |
| Q58110574 | Short-Course Antibiotic Treatment Is Not Inferior to a Long-Course One in Acute Cholangitis: A Systematic Review |
| Q41198194 | Sphincterotomy techniques and risks. |
| Q33909075 | Subclinical focal Cholangitis mimicking liver metastasis in asymptomatic patients with history of pancreatic Ductal Adenocarcinoma and Biliary tree intervention |
| Q70062390 | Surgical relief of obstructive jaundice in a district general hospital |
| Q70303835 | The clinical and pathologic correlations in mechanical biliary obstruction and acute cholangitis |
| Q40798200 | The treatment of acute cholangitis. Percutaneous transhepatic biliary drainage before definitive therapy |
| Q71776764 | Treatment of choice for choledocholithiasis in patients with acute obstructive suppurative cholangitis and liver cirrhosis |
| Q42077608 | Urgent endoscopic drainage for acute suppurative cholangitis |
| Q34206690 | What are the risk factors for acute suppurative cholangitis caused by common bile duct stones? |